Search

Dave Trong Nguyen

Supervisory Patent Examiner (ID: 2395, Phone: (571)272-0731 , Office: P/1634 )

Most Active Art Unit
1633
Art Unit(s)
1633, 1804, 1621, 1634, 1632
Total Applications
624
Issued Applications
320
Pending Applications
143
Abandoned Applications
162

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4309352 [patent_doc_number] => 06316260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/294035 [patent_app_country] => US [patent_app_date] => 1999-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7767 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316260.pdf [firstpage_image] =>[orig_patent_app_number] => 294035 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/294035
Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof Apr 18, 1999 Issued
09/290732 ADENOVIRAL VECTORS FOR TREATING DISEASE Apr 12, 1999 Abandoned
Array ( [id] => 4322405 [patent_doc_number] => 06319496 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/287221 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13320 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319496.pdf [firstpage_image] =>[orig_patent_app_number] => 287221 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/287221
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof Apr 5, 1999 Issued
Array ( [id] => 7636957 [patent_doc_number] => 06379698 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Fusogenic lipids and vesicles' [patent_app_type] => B1 [patent_app_number] => 09/287175 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8415 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379698.pdf [firstpage_image] =>[orig_patent_app_number] => 09287175 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/287175
Fusogenic lipids and vesicles Apr 5, 1999 Issued
Array ( [id] => 1560138 [patent_doc_number] => 06436908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Use of exogenous -adrenergic receptor and -adrenergic receptor kinase gene constructs to enhance myocardial function' [patent_app_type] => B1 [patent_app_number] => 09/285677 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 12907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436908.pdf [firstpage_image] =>[orig_patent_app_number] => 09285677 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/285677
Use of exogenous -adrenergic receptor and -adrenergic receptor kinase gene constructs to enhance myocardial function Apr 4, 1999 Issued
Array ( [id] => 4338751 [patent_doc_number] => 06284256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Bordetella bronchiseptica vaccine' [patent_app_type] => 1 [patent_app_number] => 9/281221 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8785 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284256.pdf [firstpage_image] =>[orig_patent_app_number] => 281221 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/281221
Bordetella bronchiseptica vaccine Mar 29, 1999 Issued
Array ( [id] => 4314651 [patent_doc_number] => 06316597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Sox-9 gene and protein and use in the regeneration of bone or cartilage' [patent_app_type] => 1 [patent_app_number] => 9/281476 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 15577 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316597.pdf [firstpage_image] =>[orig_patent_app_number] => 281476 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/281476
Sox-9 gene and protein and use in the regeneration of bone or cartilage Mar 29, 1999 Issued
Array ( [id] => 6623835 [patent_doc_number] => 20020016304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'CARRIER FOR STABILIZING NUCLEIC ACID' [patent_app_type] => new [patent_app_number] => 09/267608 [patent_app_country] => US [patent_app_date] => 1999-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10375 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016304.pdf [firstpage_image] =>[orig_patent_app_number] => 09267608 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/267608
CARRIER FOR STABILIZING NUCLEIC ACID Mar 14, 1999 Abandoned
09/266463 MICROPARTICLES FOR DELIVERY OF NUCLEIC ACID Mar 10, 1999 Abandoned
Array ( [id] => 1245584 [patent_doc_number] => 06677152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene' [patent_app_type] => B2 [patent_app_number] => 09/263178 [patent_app_country] => US [patent_app_date] => 1999-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 13990 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677152.pdf [firstpage_image] =>[orig_patent_app_number] => 09263178 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/263178
Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene Mar 4, 1999 Issued
Array ( [id] => 6128332 [patent_doc_number] => 20020076394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'DELIVERY SYSTEM FOR GENE THERAPY TO THE BRAIN' [patent_app_type] => new [patent_app_number] => 09/202564 [patent_app_country] => US [patent_app_date] => 1999-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7477 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076394.pdf [firstpage_image] =>[orig_patent_app_number] => 09202564 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/202564
Delivery system for gene therapy to the brain Feb 7, 1999 Issued
Array ( [id] => 1452627 [patent_doc_number] => 06461641 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Tumor delivery vehicles' [patent_app_type] => B1 [patent_app_number] => 09/243756 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6676 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/461/06461641.pdf [firstpage_image] =>[orig_patent_app_number] => 09243756 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/243756
Tumor delivery vehicles Feb 2, 1999 Issued
Array ( [id] => 1532192 [patent_doc_number] => 06410328 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Sensitizing cells to compounds using lipid-mediated gene and compound delivery' [patent_app_type] => B1 [patent_app_number] => 09/243104 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 12910 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410328.pdf [firstpage_image] =>[orig_patent_app_number] => 09243104 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/243104
Sensitizing cells to compounds using lipid-mediated gene and compound delivery Feb 1, 1999 Issued
Array ( [id] => 7040821 [patent_doc_number] => 20010005505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-28 [patent_title] => 'DESTRUCTION OF THE EPITHELIUM OF AN EXOCRINE GLAND IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF CANCER' [patent_app_type] => new-utility [patent_app_number] => 09/240206 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5720 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20010005505.pdf [firstpage_image] =>[orig_patent_app_number] => 09240206 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/240206
Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer Jan 28, 1999 Issued
Array ( [id] => 4324147 [patent_doc_number] => 06312683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Equine infectious anemia virus vectors' [patent_app_type] => 1 [patent_app_number] => 9/238356 [patent_app_country] => US [patent_app_date] => 1999-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 38 [patent_no_of_words] => 28464 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312683.pdf [firstpage_image] =>[orig_patent_app_number] => 238356 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/238356
Equine infectious anemia virus vectors Jan 26, 1999 Issued
Array ( [id] => 4403999 [patent_doc_number] => 06264941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules' [patent_app_type] => 1 [patent_app_number] => 9/236246 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22603 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264941.pdf [firstpage_image] =>[orig_patent_app_number] => 236246 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/236246
Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules Jan 24, 1999 Issued
Array ( [id] => 7629730 [patent_doc_number] => 06818626 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Chelating systems for use in the delivery of compounds to cells' [patent_app_type] => B1 [patent_app_number] => 09/234606 [patent_app_country] => US [patent_app_date] => 1999-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10554 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818626.pdf [firstpage_image] =>[orig_patent_app_number] => 09234606 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/234606
Chelating systems for use in the delivery of compounds to cells Jan 20, 1999 Issued
Array ( [id] => 1600900 [patent_doc_number] => 06475995 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Oral delivery of nucleic acid vaccines by particulate complexes' [patent_app_type] => B1 [patent_app_number] => 09/232167 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 9661 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475995.pdf [firstpage_image] =>[orig_patent_app_number] => 09232167 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/232167
Oral delivery of nucleic acid vaccines by particulate complexes Jan 14, 1999 Issued
Array ( [id] => 1594124 [patent_doc_number] => 06383814 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Cationic amphiphiles for intracellular delivery of therapeutic molecules' [patent_app_type] => B1 [patent_app_number] => 09/228232 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 28 [patent_no_of_words] => 25760 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383814.pdf [firstpage_image] =>[orig_patent_app_number] => 09228232 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/228232
Cationic amphiphiles for intracellular delivery of therapeutic molecules Jan 10, 1999 Issued
Array ( [id] => 4302694 [patent_doc_number] => 06326195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Recombinant retroviral vector' [patent_app_type] => 1 [patent_app_number] => 9/225509 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12666 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326195.pdf [firstpage_image] =>[orig_patent_app_number] => 225509 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/225509
Recombinant retroviral vector Jan 5, 1999 Issued
Menu